Acrobiosystems Co Ltd
SZSE:301080

Watchlist Manager
Acrobiosystems Co Ltd Logo
Acrobiosystems Co Ltd
SZSE:301080
Watchlist
Price: 42.77 CNY -6.31% Market Closed
Market Cap: 5.1B CNY
Have any thoughts about
Acrobiosystems Co Ltd?
Write Note

Acrobiosystems Co Ltd
Cash Paid for Dividends

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Acrobiosystems Co Ltd
Cash Paid for Dividends Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Paid for Dividends CAGR 3Y CAGR 5Y CAGR 10Y
Acrobiosystems Co Ltd
SZSE:301080
Cash Paid for Dividends
-ÂĄ120m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash Paid for Dividends
-ÂĄ141.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash Paid for Dividends
-ÂĄ907.5m
CAGR 3-Years
-711%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Cash Paid for Dividends
-ÂĄ247.2m
CAGR 3-Years
-2%
CAGR 5-Years
-39%
CAGR 10-Years
-12%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash Paid for Dividends
-ÂĄ104.4m
CAGR 3-Years
52%
CAGR 5-Years
34%
CAGR 10-Years
-3%
Imeik Technology Development Co Ltd
SZSE:300896
Cash Paid for Dividends
-ÂĄ1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Acrobiosystems Co Ltd
Glance View

Market Cap
5.1B CNY
Industry
Biotechnology

ACROBiosystems Co., Ltd. engages in the development of biomedicine and bio-protein technology. The company is headquartered in Beijing, Beijing and currently employs 397 full-time employees. The company went IPO on 2021-10-18. The firm's main products are recombinant proteins and detection services, as well as kits, antibodies, fillers, culture media and other related products. The firm's main products and services are applied to research and development (R&D) and production links such as early drug discovery and verification, drug screening and optimization, development and optimization of diagnostic reagents, preclinical and clinical trials, drug production process and process control (CMC) of tumors, autoimmune diseases, cardiovascular diseases, infectious diseases and other diseases.

Intrinsic Value
49.48 CNY
Undervaluation 14%
Intrinsic Value
Price

See Also

What is Acrobiosystems Co Ltd's Cash Paid for Dividends?
Cash Paid for Dividends
-120m CNY

Based on the financial report for Dec 31, 2023, Acrobiosystems Co Ltd's Cash Paid for Dividends amounts to -120m CNY.

What is Acrobiosystems Co Ltd's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 1Y
0%

Over the last year, the Cash Paid for Dividends growth was 0%.

Back to Top